171 related articles for article (PubMed ID: 26980037)
1. ARID1A expression in early stage colorectal adenocarcinoma: an exploration of its prognostic significance.
Lee LH; Sadot E; Ivelja S; Vakiani E; Hechtman JF; Sevinsky CJ; Klimstra DS; Ginty F; Shia J
Hum Pathol; 2016 Jul; 53():97-104. PubMed ID: 26980037
[TBL] [Abstract][Full Text] [Related]
2. Switch/sucrose nonfermenting nucleosome complex-deficient colorectal carcinomas have distinct clinicopathologic features.
Villatoro TM; Ma C; Pai RK
Hum Pathol; 2020 May; 99():53-61. PubMed ID: 32222462
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic and prognostic relevance of ARID1A protein loss in colorectal cancer.
Wei XL; Wang DS; Xi SY; Wu WJ; Chen DL; Zeng ZL; Wang RY; Huang YX; Jin Y; Wang F; Qiu MZ; Luo HY; Zhang DS; Xu RH
World J Gastroenterol; 2014 Dec; 20(48):18404-12. PubMed ID: 25561809
[TBL] [Abstract][Full Text] [Related]
4. Loss of ARID1A expression is associated with DNA mismatch repair protein deficiency and favorable prognosis in advanced stage surgically resected esophageal adenocarcinoma.
Lowenthal BM; Nason KS; Pennathur A; Luketich JD; Pai RK; Davison JM; Ma C
Hum Pathol; 2019 Dec; 94():1-10. PubMed ID: 31655170
[TBL] [Abstract][Full Text] [Related]
5. Various ARID1A expression patterns and their clinical significance in gastric cancers.
Kim YB; Ham IH; Hur H; Lee D
Hum Pathol; 2016 Mar; 49():61-70. PubMed ID: 26826411
[TBL] [Abstract][Full Text] [Related]
6. ARID1A expression in gastric adenocarcinoma: clinicopathological significance and correlation with DNA mismatch repair status.
Inada R; Sekine S; Taniguchi H; Tsuda H; Katai H; Fujiwara T; Kushima R
World J Gastroenterol; 2015 Feb; 21(7):2159-68. PubMed ID: 25717252
[TBL] [Abstract][Full Text] [Related]
7. Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer.
Korphaisarn K; Pongpaibul A; Limwongse C; Roothumnong E; Klaisuban W; Nimmannit A; Jinawath A; Akewanlop C
World J Gastroenterol; 2015 Jan; 21(3):926-34. PubMed ID: 25624727
[TBL] [Abstract][Full Text] [Related]
8. Loss of INI1 expression in colorectal carcinoma is associated with high tumor grade, poor survival, BRAFV600E mutation, and mismatch repair deficiency.
Wang J; Andrici J; Sioson L; Clarkson A; Sheen A; Farzin M; Toon CW; Turchini J; Gill AJ
Hum Pathol; 2016 Sep; 55():83-90. PubMed ID: 27184481
[TBL] [Abstract][Full Text] [Related]
9. Loss of ARID1A expression in colorectal carcinoma is strongly associated with mismatch repair deficiency.
Chou A; Toon CW; Clarkson A; Sioson L; Houang M; Watson N; DeSilva K; Gill AJ
Hum Pathol; 2014 Aug; 45(8):1697-703. PubMed ID: 24925223
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of ARID1A in colorectal carcinoma: loss of staining is associated with sporadic microsatellite unstable tumors with medullary histology and high TNM stage.
Ye J; Zhou Y; Weiser MR; Gönen M; Zhang L; Samdani T; Bacares R; DeLair D; Ivelja S; Vakiani E; Klimstra DS; Soslow RA; Shia J
Hum Pathol; 2014 Dec; 45(12):2430-6. PubMed ID: 25311944
[TBL] [Abstract][Full Text] [Related]
11. Loss of Hes1 expression is associated with poor prognosis in colorectal adenocarcinoma.
Ahadi M; Andrici J; Sioson L; Sheen A; Clarkson A; Gill AJ
Hum Pathol; 2016 Nov; 57():91-97. PubMed ID: 27476040
[TBL] [Abstract][Full Text] [Related]
12. DNA mismatch repair deficiency but not ARID1A loss is associated with prognosis in small intestinal adenocarcinoma.
González I; Goyal B; Xia MD; Pai RK; Ma C
Hum Pathol; 2019 Mar; 85():18-26. PubMed ID: 30381262
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic features of synchronous colorectal carcinoma: A distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis.
Hu H; Chang DT; Nikiforova MN; Kuan SF; Pai RK
Am J Surg Pathol; 2013 Nov; 37(11):1660-70. PubMed ID: 23887157
[TBL] [Abstract][Full Text] [Related]
14. SATB2 and CDX2 are prognostic biomarkers in DNA mismatch repair protein deficient colon cancer.
Ma C; Olevian D; Miller C; Herbst C; Jayachandran P; Kozak MM; Chang DT; Pai RK
Mod Pathol; 2019 Jul; 32(8):1217-1231. PubMed ID: 30962505
[TBL] [Abstract][Full Text] [Related]
15. Loss of stromal caveolin-1 expression in colorectal cancer predicts poor survival.
Zhao Z; Han FH; Yang SB; Hua LX; Wu JH; Zhan WH
World J Gastroenterol; 2015 Jan; 21(4):1140-7. PubMed ID: 25632186
[TBL] [Abstract][Full Text] [Related]
16. LSF expression and its prognostic implication in colorectal cancer.
Jiang H; Du J; Jin J; Qi X; Pu Y; Fei B
Int J Clin Exp Pathol; 2014; 7(9):6024-31. PubMed ID: 25337247
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of AT-rich interactive domain 1A in hepatocellular carcinoma.
Abe H; Hayashi A; Kunita A; Sakamoto Y; Hasegawa K; Shibahara J; Kokudo N; Fukayama M
Int J Clin Exp Pathol; 2015; 8(3):2763-70. PubMed ID: 26045782
[TBL] [Abstract][Full Text] [Related]
18. Keratin 20 - a diagnostic and prognostic marker in colorectal cancer?
Harbaum L; Pollheimer MJ; Kornprat P; Lindtner RA; Schlemmer A; Rehak P; Langner C
Histol Histopathol; 2012 Mar; 27(3):347-56. PubMed ID: 22237712
[TBL] [Abstract][Full Text] [Related]
19. Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients.
Bae JM; Lee TH; Cho NY; Kim TY; Kang GH
World J Gastroenterol; 2015 Feb; 21(5):1457-67. PubMed ID: 25663765
[TBL] [Abstract][Full Text] [Related]
20. Combination of p53 expression and p21 loss has an independent prognostic impact on sporadic colorectal cancer.
Noske A; Lipka S; Budczies J; Müller K; Loddenkemper C; Buhr HJ; Kruschewski M
Oncol Rep; 2009 Jul; 22(1):3-9. PubMed ID: 19513497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
